Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 9c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance